[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Colgate Palmolive\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":180},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,47,76,99,121,142,160],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100644143","phase-3-comparative-efficacy-of-different-dentin-occluding-toothpaste-technologies-100644143",false,"NCT07664592","Comparative Efficacy of Different Dentin Occluding Toothpaste Technologies","Comparative Efficacy of Different Dentin Occluding Toothpaste Technologies on Instant and Short-term Relief of Dentin Hypersensitivity: a Randomized Clinical Trial","SENSBZ","Inclusion Criteria:\n\n1. Sign an Informed Consent Form;\n2. Male or female 18 to 70 years of age, inclusive;\n3. Be in good general health as determined by the study investigators (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve\u002Fhip replacements, etc);\n4. Willingness to provide information related to their medical history;\n5. Available for the two (2) weeks duration of the study;\n6. Minimum of 16 uncrowned permanent natural teeth (excluding third molars and crowns);\n7. Must present at least two (2) sensitive teeth which must meet ALL of the following criteria:\n\n   1. Be anterior to the molars and demonstrating dentin exposure due to cervical erosion\u002Fabrasion and\u002For gingival recession;\n   2. Have a qualifying dentin hypersensitivity response to air blast stimuli applied for one second to the cervical surface (gingivo-facial 1\u002F3) as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.\n\nExclusion Criteria:\n\n1. Gross oral pathology, chronic disease, and\u002For history of allergies to any of the test products;\n2. Use of a desensitizing oral care product and\u002For recipient of any dental desensitizing treatment within the past month prior to start of the study;\n3. Advanced periodontal disease and\u002For treatment for periodontal disease (including surgery) within the past twelve months, dental cleaning it's permitted;\n4. Sensitive teeth with a mobility greater than one;\n5. Teeth with extensive\u002Fdefective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures;\n6. Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, daily use of analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; to be defined by the dental examiner; or other drugs that could affect pain sensation;\n7. Current smokers and subjects with a history of alcohol or drug abuse;\n8. Participation in any other oral clinical study for the duration of this study;\n9. Self-reported pregnancy and\u002For currently breastfeeding;\n10. Allergies to oral care products, personal care consumer products, and\u002For their ingredients;\n11. Medical condition which prohibits not eating\u002Fdrinking for 4 hours.\n12. Extended use of antibiotics or therapeutic mouthwash (eg: Chlorhexidine) any time during the three months prior to entry into the study;\n13. Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine);\n14. Current use of orthodontic appliances (including fixed braces, clear aligners, or permanent retainers)","ALL","18 Years","70 Years",{"count":21,"type":22},132,"ESTIMATED","INTERVENTIONAL",[25],"PHASE3","The purpose of this clinical study is to evaluate and compare how well three different types of toothpaste technologies work to relieve tooth sensitivity, also known as dentin hypersensitivity. The study asks the question: How effective are toothpastes containing 8% Arginine, 8% Arginine with Zinc Phosphate, or 5% Calcium Sodium Phosphosilicate (CSPS) at providing immediate and short-term relief for people suffering from sensitive teeth?",[28,29],"Dentinal Sensitivity","Dentinal Hypersensitivity",[31,32,33,34],"Dentin Hypersensitivity","Arginine","Oral Health Quality of Life","Sensitive Teeth","NOT_YET_RECRUITING","2026-06-18",{"date":38,"type":39},"2026-06-24","ACTUAL",{"date":41,"type":22},"2026-06-29",{"date":43,"type":22},"2026-09-30",{"name":45,"class":46},"Colgate Palmolive","INDUSTRY",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":56,"targetDuration":4,"studyType":23,"phases":58,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},"100639820","phase-3-clinical-study-to-evaluate-remineralization-using-an-in-situ-model-100639820","NCT07625670","Clinical Study to Evaluate Remineralization Using an in Situ Model.","Clinical Study to Evaluate Enamel Remineralization Using Three Dentifrices in an in Situ Model.","REMINSITU","Inclusion Criteria:\n\n* Males and females, between 18-70 years of age (inclusive);\n* Informed Consent Form signed and availability for the duration of the study;\n* Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve\u002Fhip replacements, etc);\n* Willingness to provide information related to their medical history;\n* Minimum of 20 uncrowned permanent natural teeth (excluding third molars);\n* Normal salivary flow;\n* Willingness to wear an intra-oral appliance all day as instructed except when eating and drinking.\n\nExclusion Criteria:\n\n* Oral pathology, chronic disease, or a history of allergy to testing products;\n* Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study;\n* Subject participating in any other clinical study;\n* Subject pregnant or breastfeeding;\n* Subject allergic to oral care products, personal care consumer products, or their ingredients;\n* Extended use of antibiotics or therapeutic mouthwash any time during the three months prior to entry into the study;\n* A medical history reporting that the subject has a current systemic or autoimmune disease, such as diabetes, lupus, etc.;\n* Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine);\n* Advanced periodontal disease (purulent exudate, tooth mobility, and\u002For extensive loss of periodontal attachment or alveolar bone). Pocket depth equal or greater than 4 mm;\n* Five or more decayed, untreated dental sites (cavities);\n* Current smokers and subjects with a history of alcohol or drug abuse;\n* Dental work prevents wearing of the appliance or a reported need to wear a night guard.",true,{"count":57,"type":22},30,[25],"This is a phase III clinical trial that aims to evaluate the enamel remineralization efficacy of three dentifrices on artificial caries lesions using an in situ model. The study involves 30 healthy volunteers, aged 18 to 70, who will participate in a randomized, triple-blind, three-period crossover design. Researchers will compare a 750 ppm MFP dentifrice against a 1450 ppm MFP positive control and a fluoride-free negative control to measure variations in mineral gain. Participants will wear a removable intraoral appliance containing human enamel blocks for three 14-day experimental phases. A 7-day washout period using will be implemented before and between each treatment phase.",[61,62,63],"Remineralization","Enamel Lesions","Enamel Subsurface Lesion",[65,66],"enamel remineralization","transverse micro-radiography","2026-06-02",{"date":69,"type":39},"2026-06-04",{"date":71,"type":22},"2026-06",{"date":73,"type":22},"2026-10",{"name":45,"class":46},1,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":23,"phases":84,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":75},"100640564","phase-4-clinical-study-to-collect-and-analyze-dental-plaque-and-oral-health-measures-in-a-population-with-high-plaquelow-gingivitis-and-high-plaquehigh-gingivitis-100640564","NCT07614490","Clinical Study to Collect and Analyze Dental Plaque and Oral Health Measures in a Population With High Plaque\u002FLow Gingivitis and High Plaque\u002FHigh Gingivitis","Inclusion Criteria:\n\n* Male or female volunteers at least 18 years of age and in general good health.\n* Willing and able to understand and sign the informed consent form.\n* Must have a whole mouth mean TPI score ≥ 3.25\n* N=40 must have moderate-severe gingivitis (Whole Mouth Mean MGI≥2.5 or percent bleeding sites based on EBI ≥20%) and N=40 must have mild gingivitis (Whole Mouth Mean MGI≤2.5 and percent bleeding sites based on EBI\\\u003C20%)\n* Must have at least two areas in the mouth with high plaque\u002Flow inflammation and two areas with high plaque\u002Fhigh inflammation\n* Be willing to conform to the study protocol and procedures.\n* Minimum of 20 natural teeth with scorable facial and lingual surfaces\n\nExclusion Criteria:\n\n* Medical condition which requires premedication prior to dental visits\u002Fprocedure.\n* Known history of allergy to personal care\u002Fconsumer products or their ingredients, relevant to any ingredients in the test products as determined by the study examiner.\n* Active disease of the hard oral tissues.\n* Significant oral soft tissue pathology, excluding plaque-induced gingivitis.\n* Subjects with fixed or removable orthodontic appliances or removable partial dentures.\n* Dental prophylaxis within 30 days prior to study start.\n* Use of antibiotics, antimicrobial drugs, anti-inflammatory drugs, or anticoagulant therapies within 30 days prior to study start.\n* Use of chemotherapeutic oral care products within two weeks prior to study start.\n* Participation in any other clinical study within 30 days prior to enrollment into this study.\n* Subjects who must receive dental treatment during the study dates.\n* Immunocompromised individuals (HIV, AIDS, immunosuppressive drug therapy).\n* Use of smokeless tobacco, vaping, or e-cigarettes or suspected substance abuse.\n* Current smokers (if former smoker, should have stopped at least 1 month prior to Visit 1)\n* Pregnant or lactating subjects, or subjects planning to become pregnant during the course of the study.\n* Medical condition which prohibits not eating\u002Fdrinking or chewing gum for four (4) hours prior to your scheduled visits;\n* Subjects who have an infectious disease and\u002For other blood borne diseases (Hepatitis series, HIV, tuberculosis).",{"count":83,"type":22},100,[85],"PHASE4","The objective of this clinical research study is to collect and analyze plaque and oral health measures in a population with high plaque\u002Flow gingivitis and high plaque\u002Fhigh gingivitis",[88,89],"Gingivitis","Plaque","RECRUITING","2026-05-22",{"date":93,"type":39},"2026-05-29",{"date":95,"type":39},"2026-04-20",{"date":97,"type":22},"2026-10-15",{"name":45,"class":46},{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":103,"acronym":104,"eligibilityCriteria":105,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":106,"enrollmentInfo":107,"targetDuration":4,"studyType":23,"phases":109,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":115,"startDateStruct":117,"completionDateStruct":118,"leadSponsor":120,"locationsCount":75},"100590367","phase-4-investigation-of-the-interplay-between-local-oral-inflammation-microbiota-and-systemic-immune-responses-100590367","NCT06966492","Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.","ILIMSIR","Inclusion Criteria:\n\n1. Males and females, between 18-65 years of age;\n2. Availability for the duration of the study;\n3. ASA 1 Good general health (absence of any self-reported systemic disease or condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve\u002Fhip replacements, etc);\n4. Willingness to provide information related to their medical history;\n5. Minimum of 20 uncrowned permanent natural teeth (excluding third molars and crowns);\n6. Informed Consent Form signed.\n\nExclusion Criteria:\n\n1. Subjects with more that 2 sites with pocket depth of \\> 4 mm and those presenting purulent exudate, tooth mobility, and\u002For extensive loss of periodontal attachment or alveolar bone;\n2. Oral pathology or a history of allergy to testing products;\n3. Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; to be defined by the dental examiner;\n4. Subject participating in any other clinical study;\n5. Subject pregnant or breastfeeding;\n6. Subject allergic to oral care products and personal care consumer products\n7. Extended use of antibiotics or therapeutic mouthwash (eg: Chlorhexidine) any time during the three months prior to entry into the study;\n8. Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine)\n9. Current smokers (or users of tobacco and vaping products) and subjects with a history of alcohol or drug abuse;\n10. An existing medical condition which prohibits eating or drinking for periods up to 4 hours.\n11. Individuals with orthodontic bands or removable partial dentures.\n12. Dental prophylaxis in the previous 3 months prior to the baseline examination","65 Years",{"count":108,"type":22},20,[85],"This is a clinical research study designed to measure changes in inflammation and the oral microbiome during a phase of good oral hygiene and the absence of oral hygiene. The goal of the study is to investigate the interplay between local oral inflammation, microbiota and systemic immune responses.",[112],"Gingival Inflammation",[114],"induced gingivitis",{"date":116,"type":39},"2026-05-26",{"date":71,"type":22},{"date":119,"type":22},"2027-06",{"name":45,"class":46},{"id":122,"slug":123,"hasResults":11,"nctId":124,"briefTitle":125,"officialTitle":126,"acronym":4,"eligibilityCriteria":127,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":128,"targetDuration":4,"studyType":23,"phases":130,"briefSummary":131,"conditions":132,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":75},"100631318","phase-3-efficacy-of-a-toothpaste-in-reducing-plaque-gingivitis-and-gingival-bleeding-100631318","NCT07499115","Efficacy of a Toothpaste in Reducing Plaque, Gingivitis, and Gingival Bleeding","Clinical Investigation of the Efficacy of a Toothpaste Containing Chitosan in Reducing Plaque, Gingivitis, and Gingival Bleeding","Inclusion Criteria:\n\n* Male or female, aged 18-70 years (inclusive).\n* Available for the duration of the study.\n* Able to understand and willing to read and sign the Informed Consent Form after the nature of the study has been fully explained.\n* Willing to comply with all study procedures and clinical examination schedules.\n* Good general health (absence of any condition that, in the opinion of the study examiner, might pose risk during participation; e.g., certain heart conditions, valve\u002Fhip replacements).\n* Presence of at least 20 natural teeth (excluding third molars) with scorable facial and lingual surfaces.\n* Mean Modified Gingival Index (MGI, Lobene) ≥ 2.0 and Mean Modified Plaque Index (MPI, Turesky) ≥ 1.5 at screening.\n* Willing and able to complete study questionnaires on product usage experience during routine toothbrushing.\n\nExclusion Criteria:\n\n* Pregnant or lactating.\n* Use of tobacco products.\n* History of alcohol or drug abuse.\n* Any medical condition (e.g., significant heart or liver disease, bleeding disorders, blood dyscrasias) or current medication use that, in the investigator's judgment, may compromise subject safety or the quality of study results.\n* Medical condition requiring pre-medication prior to dental visits\u002Fprocedures.\n* History of allergy to oral hygiene products.\n* Use of anti-inflammatory, immunosuppressive, antimicrobial, or anticoagulant drugs, or antibiotics within 30 days prior to study start or during the study.\n* Ongoing use of medications known to affect gingival tissues (e.g., calcium channel blockers, phenytoin, cyclosporine).\n* Presence of orthodontic bands or removable partial dentures.\n* Tumors of the soft or hard tissues of the oral cavity.\n* Five or more carious lesions requiring immediate restorative treatment.\n* More than two periodontal pockets (\\>4 mm) with bleeding on probing.\n* Any gingival condition (e.g., hyperplasia or overgrowth) that would interfere with clinical assessment.\n* Participation in another clinical study with an oral care indication or test panel within 30 days prior to study start.\n* Medical condition that prohibits abstaining from eating or drinking for up to 2 hours.",{"count":129,"type":22},90,[25],"To assess the efficacy of a toothpaste containing chitosan in reducing plaque, gingivitis, and gingival bleeding, compared with Colgate Cavity Protection Toothpaste",[133,88],"Plaque, Dental","2026-04-07",{"date":136,"type":39},"2026-04-13",{"date":138,"type":22},"2026-04",{"date":140,"type":22},"2026-07",{"name":45,"class":46},{"id":143,"slug":144,"hasResults":11,"nctId":145,"briefTitle":146,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":149,"targetDuration":4,"studyType":23,"phases":150,"briefSummary":151,"conditions":152,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":159,"locationsCount":4},"100628194","phase-3-a-study-to-investigate-stannous-fluoride-containing-toothpaste-on-antibacterial-effects-in-the-different-regions-of-the-mouth-100628194","NCT07458464","A Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the Mouth","A Clinical Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the Mouth as Compared to Colgate Cavity Protection Toothpaste.","Inclusion Criteria:\n\n* Male and female subjects, ages 18-70, inclusive.\n* Subject is available during study duration and has no allergies to oral hygiene formulations.\n* A minimum of 20 natural teeth with facial and lingual scorable surfaces.\n* A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and clinical examination schedules.\n* Subjects with a baseline whole mouth scores of dental plaque of 1.5 or more \\[Turesky Modification of Quigley-Hein\\] and gingivitis index of 1.0 or more \\[Loe-Silness\\].\n\nExclusion Criteria:\n\n* Participation in any other clinical study or test panel including clinical studies with oral hygiene formulations within the one month prior to entry into the study.\n* History of dental prophylaxis or treatments in the past month or during study duration.\n* History of medical treatments including antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding study enrollment.\n* Subjects scheduled for medical procedures for the duration of the study.\n* Difficulty complying with study procedures and examinations such as excessive gagging during oral assessment etc.\n* History of significant adverse effects following use of oral hygiene products such as toothpastes and mouth rinses. Allergy to personal care\u002Fconsumer products or their ingredients.\n* History of diabetes or hepatic or renal disease, or medical or inflammatory conditions or transmittable diseases, e.g. heart disease or AIDS.\n* History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.\n* Oral soft tissue pathology.\n* History of active or severe periodontal disease and loose teeth.\n* Gross dental caries, severe generalized cervical abrasion and\u002For enamel abrasion, large fractured or temporary restorations (based on visual examinations).\n* Fixed or removable orthodontic appliance or removable partial dentures.\n* Self-reported pregnancy or lactation.\n* Subjects known to be an alcoholic, or a recovering alcoholic.",{"count":83,"type":22},[25],"The clinical study will examine the effects of brushing with randomly assigned test toothpaste on the bacteria on the dental plaque, tongue, cheek, gum surface, and in saliva",[89,88],"2026-03-04",{"date":155,"type":39},"2026-03-09",{"date":157,"type":22},"2026-05",{"date":71,"type":22},{"name":45,"class":46},{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":165,"acronym":4,"eligibilityCriteria":166,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":167,"targetDuration":4,"studyType":23,"phases":168,"briefSummary":169,"conditions":170,"keywords":4,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":75},"100624787","phase-4-6-month-clinical-investigation-assessing-the-efficacy-of-an-antimicrobial-mouthrinse-in-reducing-established-plaque-and-improving-gum-health-100624787","NCT07414173","6-month Clinical Investigation Assessing the Efficacy of an Antimicrobial Mouthrinse in Reducing Established Plaque and Improving Gum Health","Clinical Investigation to Assess the Efficacy of an Antimicrobial Mouthrinse in the Reduction of Established Plaque and the Improvement of Gum Health: a 6-month Clinical Study","Inclusion Criteria:\n\n1. Male and female subjects aged 18-70 years, inclusive.\n2. Availability for the 6-month duration of the clinical research study.\n3. Good general health based on the opinion of the study investigator.\n4. Signed Informed Consent Form.\n5. Minimum of 20 natural teeth (excluding third molars).\n6. Initial gingivitis index of at least 1.5 as determined by the use of the Loe and Silness Gingival Index.\n7. Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).\n\nExclusion Criteria:\n\n1. Be under orthodontic treatment.\n2. Presence of partial removable dentures.\n3. Tumor(s) of the soft or hard tissues of the oral cavity.\n4. Participants with current moderate or severe periodontitis (periodontitis screening index \\[PSI\\] \\>2 in more than 2 sextants or PSI \\>3), and\u002For purulent exudate, tooth mobility, and\u002For extensive loss of periodontal attachment or alveolar bone.\n5. Five or more carious lesions requiring immediate restorative treatment.\n6. Antibiotic use any time during the one-month period prior to entry into the study.\n7. Participation in any other clinical study or test panel within the one month prior to entry into the study.\n8. Dental prophylaxis during the past two weeks prior to baseline examinations.\n9. History of allergies to oral care\u002Fpersonal care consumer products or their ingredients.\n10. On any prescription medicines that might interfere with the study outcome based on the examiner\u002FPI opinion.\n11. An existing medical condition that prohibits eating and\u002For drinking for periods up to 4 hours.\n12. History of alcohol and\u002For drug abuse.\n13. Self-reported pregnancy and\u002For lactating subjects.\n14. Subjects with other oral diseases (including gingival hyperplasia, diseases of the oral mucosa), or any condition that the dental examiner considers exclusionary from the study.\n15. Smokers or\u002Fand users of tobacco products.\n16. Enrolled in an undergraduate, postgraduate, or academic dentistry program",{"count":129,"type":22},[85],"The goal of this clinical trial is to evaluate the clinical efficacy of an antimicrobial mouthrinse, with a particular focus on its effect on established plaque and the improvement of gum health.\n\nParticipants will:\n\n* Brush and rinse twice a day with the designated products for 6 months\n* Visit the clinic once every 3 months after baseline for reassessment.",[88,171],"Dental Plaque Accumulation","2026-02-10",{"date":174,"type":39},"2026-02-17",{"date":176,"type":39},"2026-01-28",{"date":178,"type":22},"2026-11",{"name":45,"class":46},""]